Autor:	Thaíssa Antunes Mattar Valente, Andreas Funke, Salun Coelho Aragão, André Luís De Souza Andretta, Gabriel Caetano Pereira, Ana Luisa Woidello Miyazima, Thais Miranda da Silva de Andrade, Eduardo dos Santos Paiva, Ana Cristina Boni Brandão Lenci Marques, Mariana Lechitzki, Nathan Marostica Catolino
Rok vydání:	2021
Předmět:	business.industry Low dose Immunology medicine Rituximab business Immune thrombocytopenia medicine.drug
Zdroj:	Anais do Congresso Brasileiro de Reumatologia 2020.
DOI:	10.47660/cbr.2020.17071
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::a115fa101b3a7e95968a2848318fc1bf https://doi.org/10.47660/cbr.2020.17071 Zobrazit plný text záznamu